# Raúl Rodríguez Escobedo

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/raul-rodriguez-escobedo/

## Facts

| Field | Value |
| --- | --- |
| Citations | 79 |
| Field | Diabetes Management and Research |
| h-index | 6 |
| i10-index | 1 |
| OpenAlex ID | https://openalex.org/A5003787836 |
| ORCID iD | 0000-0002-1079-6781 |
| Works | 29 |

## Researcher papers

- [Incidence of type 1 diabetes mellitus in Asturias (Spain) between 2011 and 2020](https://scholariq.org/papers/incidence-of-type-1-diabetes-mellitus-in-asturias-spain-between-2011-and-2020/)
- [Correlation between glucose measurement parameters of continuous flash monitoring and HbA1c. Real life experience in Asturias](https://scholariq.org/papers/correlation-between-glucose-measurement-parameters-of-continuous-flash/)
- [Reclassification of type 2 diabetes to type 1 diabetes in Asturias (Spain) between 2011 and 2020](https://scholariq.org/papers/reclassification-of-type-2-diabetes-to-type-1-diabetes-in-asturias-spain-between/)
- [Enfermedades cardiovasculares en personas con diabetes mellitus en España según la Base de Datos Clínicos de Atención Primaria (BDCAP) en 2017](https://scholariq.org/papers/enfermedades-cardiovasculares-en-personas-con-diabetes-mellitus-en-espana-segun/)
- [Experience after switching from insulin glargine U100 to glargine U300 in patients with type 1 diabetes mellitus. A study after one year of treatment in real life](https://scholariq.org/papers/experience-after-switching-from-insulin-glargine-u100-to-glargine-u300-in/)
- [Incidencia de la diabetes mellitus tipo 1 en Asturias entre 2011 y 2020](https://scholariq.org/papers/incidencia-de-la-diabetes-mellitus-tipo-1-en-asturias-entre-2011-y-2020/)
- [Efectividad y seguridad del tratamiento con iPCSK9 en vida real: experiencia de tres hospitales asturianos](https://scholariq.org/papers/efectividad-y-seguridad-del-tratamiento-con-ipcsk9-en-vida-real-experiencia-de/)
- [Efficacy in size and symptom reduction of radiofrequency ablation of benign non-functioning thyroid nodules](https://scholariq.org/papers/efficacy-in-size-and-symptom-reduction-of-radiofrequency-ablation-of-benign-non/)
- [Cardiovascular diseases in people with diabetes mellitus in Spain according to the Primary Care Clinical Database (BDCAP) in 2017](https://scholariq.org/papers/cardiovascular-diseases-in-people-with-diabetes-mellitus-in-spain-according-to/)
- [Efficacy in size and symptom reduction of radiofrequency ablation of benign non-functioning thyroid nodules](https://scholariq.org/papers/efficacy-in-size-and-symptom-reduction-of-radiofrequency-ablation-of-benign-non-2/)

## Researcher topics

- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Diabetes and associated disorders](https://scholariq.org/topics/diabetes-and-associated-disorders/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.